相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PBK/TOPK: A Therapeutic Target Worthy of Attention
Ziping Han et al.
CELLS (2021)
PBK/TOPK promotes chemoresistance to oxaliplatin in hepatocellular carcinoma cells by regulating PTEN
Hongmin Cao et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)
Breast cancer
Sibylle Loibl et al.
LANCET (2021)
Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
Miguel A. Ortega et al.
JOURNAL OF ONCOLOGY (2020)
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Anoop P. Patel et al.
LANCET NEUROLOGY (2019)
PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway
Qiu-Xia Yang et al.
CANCER LETTERS (2019)
Glycyrol exerts potent therapeutic effect on lung cancer via directly inactivating T-LAK cell-originated protein kinase
Shangyun Lu et al.
PHARMACOLOGICAL RESEARCH (2019)
Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer
Yi Zhang et al.
JOURNAL OF CANCER (2019)
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
Kazuhiro Araki et al.
BREAST CANCER (2018)
Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer
Armando E. Giuliano et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Epidemiology of gynecologic cancers in China
Xiyi Jiang et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
Takuma Ohashi et al.
BRITISH JOURNAL OF CANCER (2017)
Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma
Takuma Ohashi et al.
ANTICANCER RESEARCH (2016)
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
Angel Guerrero-Zotano et al.
CANCER AND METASTASIS REVIEWS (2016)
Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation
Sumin Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
Chin-Fang Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Roles of Immunohistochemical Staining in Diagnosing Pulmonary Squamous Cell Carcinoma
Yue Yan et al.
Asian Pacific Journal of Cancer Prevention (2015)
PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
Xiaoyan Dou et al.
CANCER CELL INTERNATIONAL (2015)
PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in Lung adenocarcinoma
Bin Lei et al.
HUMAN PATHOLOGY (2015)
Breast cancer risk factors
Marzena Kaminska et al.
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY (2015)
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
Patrick C. O'Leary et al.
BMC CANCER (2013)
TOPK and PTEN participate in CHFR mediated mitotic checkpoint
Swapnil R. Shinde et al.
CELLULAR SIGNALLING (2013)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
TOPK promotes tumour cell proliferation through p38MAPK activity and regulation of the DNA damage response
V. Ayllon et al.
ONCOGENE (2007)
PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer
Jae-Hyun Park et al.
CANCER RESEARCH (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
XJ Cui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Characterization of a MAPKK-like protein kinase TOPK
S Matsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Prognostic and predictive factors in early-stage breast cancer
M Cianfrocca et al.
ONCOLOGIST (2004)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells
Y Abe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Characterization of PDZ-binding kinase, a mitotic kinase
S Gaudet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)